Pharmacologic Considerations in the Treatment of Anxiety and Depression in Medical Practice
- 1 March 1971
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 55 (2) , 485-494
- https://doi.org/10.1016/s0025-7125(16)32534-2
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Hazards Implicit in Prescribing Psychoactive DrugsScience, 1970
- Clinical use of psychotherapeutic drugs: Current statusClinical Pharmacology & Therapeutics, 1969
- Drug Use in Outpatient TreatmentAmerican Journal of Psychiatry, 1968
- Amitriptyline and Amitriptyline-with-Perphenazine in Depression—A Retrospective StudyThe British Journal of Psychiatry, 1967
- Developments in PsychopharmacologyPsychosomatics, 1966
- Some Comments on Non-Drug Factors In Psychiatric Drug TherapyPsychosomatics, 1965
- Imipramine and Thioridazine in Depressed and Schizophrenic PatientsJAMA, 1964
- HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORSThe Lancet, 1963
- The Brief Psychiatric Rating ScalePsychological Reports, 1962
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960